Molecular model of hexokinase binding to the outer mitochondrial membrane porin (VDAC1): Implication for the design of new cancer therapies

Mitochondrion

Volumn 11, Issue 3, 2011, Pages 513-519

  Rosano, Camillo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Apoptosis; Cancer; Docking simulations; Hexokinase; Mitochondrial outer membrane permeabilization; Protein modeling; VDAC1

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEXOKINASE 1; VOLTAGE DEPENDENT ANION CHANNEL 1;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER THERAPY; CELL PROTECTION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME BINDING; ENZYME LOCALIZATION; MITOCHONDRIAL MEMBRANE; MOLECULAR DOCKING; MOLECULAR MODEL; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE;

HEXOKINASE; HUMANS; MITOCHONDRIAL MEMBRANES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; VOLTAGE-DEPENDENT ANION CHANNEL 1;

EID: 79953766008     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2011.01.012     Document Type: Article

References (50)

1. Abu-Hamad S., Zaid H., Israelson A., Nahon E., Shoshan-Barmatz V. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. J. Biol. Chem. 2008, 283:13482-13490.
2. Abu-Hamad S., Arbel N., Calo D., Arzoine L., Israelson A., Keinan N., Ben-Romano R., Friedman O., Shoshan-Barmatz V. The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins. J. Cell Sci. 2009, 122:1906-1916.
3. Arzoine L., Zilberberg N., Ben-Romano R., Shoshan-Barmatz V. Voltage-dependent anion channel 1 based peptides interact with hexokinase to prevent its anti-apoptotic activity. J. Biol. Chem. 2009, 284:3946-3955.
4. Bayrhuber M., Meins T., Habeck M., Becker S., Giller K., Villinger S., Vonrhein C., Griesinger C., Zweckstetter M., Zeth K. Proc. Natl Acad. Sci. USA 2008, 105:15370-15375.
5. Bernardi P. Mitochondrial transport of cations: channels, exchangers and permeability transition. Phys. Rev. 1998, 79:1127-1155.
6. Blachly-Dyson E., Forte M. VDAC channels. IUBMB Life 2001, 52:113-118.
7. Brunger A.T., Adams P.D., Clor G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., Warren G.L. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 1998, 54:905-921.
8. Bustamante E., Pedersen P.L. High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc. Natl Acad. Sci. USA 1977, 74:3735-3739.
9. Bustamante E., Morris H.P., Pedersen P.L. Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J. Biol. Chem. 1981, 256:8699-8704.
10. Debatin K.M., Poncet D., Kroemer G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 2002, 21:8786-8803.
11. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:2126-2132.
12. Ferri K.F., Kroemer G. Mitochondria-the suicide organelles. Bioessays 2001, 23:111-115.
13. Goldin N., Arzoine L., Heyfets A., Israelson A., Zaslavsky Z., Bravman T., Bronner V., Notcovich A., Shoshan-Barmatz V., Flescher E. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. Oncogene 2008, 27:4636-4643.
14. Hiller S., Garces R.G., Malia T.J., Orekhov W.Y., Colombini M., Wagner G. Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science 2008, 312:1206-1210.
15. Hirokawa T., Boon-Chieng S., Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998, 14:378-379.
16. Hofmann K., Stoffel W. TMbase-a database of membrane spanning proteins segments. Biol. Chem. 1993, 374:166.
17. Jo S., Kim T., Im W. Automated builder and database of protein/membrane complexes for molecular dynamics simulations. PLoS ONE 2007, 2:e880.
18. Jonas E.A. Molecular participants in mitochondrial cell death channel formation during neuronal ischemia. Exp. Neurol. 2009, 218:203-212.
19. Kroemer G., Martin S.J. Caspase-independent cell death. Nat. Med. 2005, 11:725-730.
20. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 2001, 305:567-580.
21. Lomize M.A., Lomize A.L., Pogozheva I.D., Mosberg H.I. OPM: orientations of proteins in membranes database. Bioinformatics 2006, 22:623-625.
22. Mandell J.G., Roberts V.A., Pique M.E., Kotlovyi V., Mitchell J.C., Nelson E., Tsigelny I., Ten Eyck L.F. Protein docking using continuum electrostatics and geometric fit. Prot. Eng. 2001, 14:105-113.
23. Mathupala S.P., Rempel A., Pedersen P.L. Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J. Biol. Chem. 1995, 270:16918-16925.
24. Mathupala S.P., Ko Y.H., Pedersen P.L. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg effect" and a pivotal target for effective therapy. Semin. Cancer Biol. 2009, 19:17-24.
25. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a Lamarkian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 1998, 19:1639-1662.
26. Nakashima R.A., Mangan P.S., Colombini M., Pedersen P.L. Hexokinase receptor complex in hepatoma mitochondria: evidence from N, N'-dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC. Biochemistry 1986, 25:1015-1021.
27. Nakashima R.A., Paggi M.G., Scott L.J., Pedersen P.L. Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line. Cancer Res. 1988, 48:913-919.
28. Pastorino J.G., Hoek J.B. Regulation of hexokinase binding to VDAC. J. Bioenerg. Biomembr. 2008, 40:171-182.
29. Pastorino J.G., Shulga N., Hoek J.B. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J. Biol. Chem. 2002, 277:7610-7618.
30. Pedersen P.L. Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the "Warburg effect" in cancer. J. Bioenerg. Biomembr. 2008, 40:123-126.
31. Pedersen P.L., Mathupala S., Rempel A., Geschwind J.F., Ko Y.H. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim. Biophys. Acta 2002, 1555:14-20.
32. Perevoshchikova I.V., Zorov S.D., Kotova E.A., Zorov D.B., Antonenko Y.N. Hexokinase inhibits flux of fluorescently labeled ATP through mitochondrial outer membrane porin. FEBS Lett. 2010, 584:2397-2402.
33. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
34. Rempel A., Bannasch P., Mayer D. Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochim. Biophys. Acta 1994, 1219:660-668.
35. Robey R.B., Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 2006, 25:4683-4696.
36. Rosano C., Sabini E., Murshudov G., Deriu D., Rizzi M., Bianchi M., Serafini G., Magnani M., Bolognesi M. Binding of non-catalytic ATP to human hexokinase type I highlights the structural components for enzyme:membrane association control. Structure 1999, 7:1427-1437.
37. Rose I., Warms J.V.B. Mitochondrial hexokinase. Release, rebinding and location. J. Biol. Chem. 1967, 242:1635-1645.
38. Sanner M.F., Duncan B.S., Carillo C.J., Olson A.J. Integrating computation and visualization for biomolecular analysis: an example using Python and AVS. Pac. Symp. Biocomput. 1999, 401-412.
39. Schuttelkopf A.W., van Aalten D.M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:1355-1363.
40. Shackelford G., Karplus K. Contact prediction using mutual information and neural nets. Proteins 2007, 69:159-164.
41. Shoshan-Barmatz V., Israelson A., Brdiczka D., Sheu S.S. The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. Curr. Pharm. Des. 2006, 12:2249-2270.
42. Shoshan-Barmatz V., Keinan N., Zaid H. Uncovering the role of VDAC in the regulation of cell life and death. J. Bioenerg. Biomembr. 2008, 40:183-191.
43. Shoshan-Barmatz V., Keinan N., Abu-Hamad S., Tyomkin D., Aram L. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo. Biochim. Biophys. Acta 2010, 1797:1281-1291.
44. Shulga N., Wilson-Smith R., Pastorino J.G. Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism. Cell Cycle 2009, 8:3355-3364.
45. Smith T.A. Mammalian hexokinases and their abnormal expression in cancer. Br. J. Biomed. Sci. 2000, 57:170-178.
46. Ten Eyck L.F., Mandell J., Roberts V.A., Pique M.E. Surveying molecular interactions with DOT. Proceedings of the 1995 ACM/IEEE Supercomputing Conference, San Diego 1995, IEEE Computer Society Press, Los Alamitos, California.
47. Verdonk M.L., Cole J.C., Hartshorn M.J., Murray C.W., Taylor R.D. Improved protein-ligand docking using GOLD. Proteins 2003, 52:609-623.
48. Wallace A.C., Laskowski R.A., Thornton J.M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Prot. Eng. 1995, 8:127-134.
49. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
50. Wilson J.E. Hexokinases. Rev. Physiol. Biochem. Pharmacol. 1995, 126:65-198.